Please enable JavaScript to continue using this application.

Compare $ILMN vs $MEDP | Chartloom

Compare

$ILMN vs $MEDP

Illumina Inc · Medpace Holdings Inc

ILMN

Illumina Inc

MEDP

Medpace Holdings Inc

Compare $ILMN vs $MEDP

Comparing Illumina Inc and Medpace Holdings Inc

ILMNIllumina Inc

MEDPMedpace Holdings Inc

ILMNIllumina Inc

Market cap

$42.09B

P/E (TTM)

51.59x

Forward P/E (NTM)

48.10x

Forward P/S (NTM)

8.72x

Rev growth (TTM)

4.9%

YTD performance

107.0%

52W performance

184.5%

FCF yield

2.2%

MEDPMedpace Holdings Inc

Market cap

$17.08B

P/E (TTM)

35.56x

Forward P/E (NTM)

32.69x

Forward P/S (NTM)

5.76x

Rev growth (TTM)

24.7%

YTD performance

7.2%

52W performance

15.3%

FCF yield

4.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ILMN

MEDP

Detailed metrics comparison

ILMN

Illumina Inc

MEDP

Medpace Holdings Inc

Market Cap

ILMN$42.09B

MEDP$17.08B

Enterprise Value

ILMN$43.04B

MEDP$16.58B

Price

ILMN$278.17

MEDP$612.05

P/E Ratio

ILMN51.59x

MEDP35.56x

P/S Ratio

ILMN9.37x

MEDP6.14x

EV/Sales

ILMN9.58x

MEDP5.96x

EV/EBITDA

ILMN36.11x

MEDP27.13x

P/B Ratio

ILMN14.53x

MEDP38.57x

P/FCF Ratio

ILMN45.21x

MEDP24.17x

EV/FCF

ILMN46.23x

MEDP23.46x

PEG Ratio

ILMN4.18x

MEDP2.97x

Forward P/E (NTM)

ILMN48.10x

MEDP32.69x

Forward P/S (NTM)

ILMN8.72x

MEDP5.76x

Revenue (TTM)

ILMN$4.49B

MEDP$2.78B

Revenue Growth (YoY)

ILMN4.9%

MEDP24.7%

Forward Rev Growth

ILMN6.3%

MEDP6.2%

Gross Margin (TTM)

ILMN66.4%

MEDP28.8%

Operating Margin (TTM)

ILMN19.5%

MEDP21.0%

EBITDA Margin (TTM)

ILMN26.2%

MEDP22.0%

Net Margin (TTM)

ILMN18.4%

MEDP17.7%

FCF Margin (TTM)

ILMN20.7%

MEDP25.4%

Net Income (TTM)

ILMN$825M

MEDP$492M

FCF (TTM)

ILMN$931M

MEDP$707M

EPS (TTM)

ILMN$5.39

MEDP$17.21

ROE (TTM)

ILMN31.1%

MEDP110.1%

ROA (TTM)

ILMN12.7%

MEDP24.8%

ROIC (TTM)

ILMN17.8%

MEDP110.1%

Cash

ILMN$1.04B

MEDP$503M

Debt

ILMN$1.99B

MEDP$0

Net Cash/Debt

ILMN$-951M

MEDP$503M

Current Ratio (TTM)

ILMN1.80x

MEDP0.73x

Quick Ratio (TTM)

ILMN1.25x

MEDP0.66x

Debt/Equity (TTM)

ILMN0.70x

MEDP0.00x

Debt/Assets (TTM)

ILMN0.0%

MEDP0.0%

Interest Coverage (TTM)

ILMNN/A

MEDPN/A

Net Debt/EBITDA (TTM)

ILMN0.00x

MEDP0.00x

Beta

ILMN1.43

MEDP1.11

52W Performance

ILMN184.5%

MEDP15.3%

YTD Performance

ILMN107.0%

MEDP7.2%

% from 52W High

ILMN-10.1%

MEDP-9.7%

% from 52W Low

ILMN216.1%

MEDP64.1%

Asset Turnover (TTM)

ILMN0.69x

MEDP1.41x

FCF Yield (TTM)

ILMN2.2%

MEDP4.1%

Earnings Yield (TTM)

ILMN2.0%

MEDP2.9%

Dividend Yield (TTM)

ILMNN/A

MEDPN/A

Rule of 40

ILMN25.6

MEDP50.1

EV/GP/RG

ILMN1.93

MEDP3.15

Ticker research

View ILMN research View MEDP research

Metric	ILMN Illumina Inc	MEDP Medpace Holdings Inc
Market & Valuation
Market Cap	$42.09B	$17.08B
Enterprise Value	$43.04B	$16.58B
Price	$278.17	$612.05
P/E Ratio	51.59x	35.56x
P/S Ratio	9.37x	6.14x
EV/Sales	9.58x	5.96x
EV/EBITDA	36.11x	27.13x
P/B Ratio	14.53x	38.57x
P/FCF Ratio	45.21x	24.17x
EV/FCF	46.23x	23.46x
PEG Ratio	4.18x	2.97x
Forward P/E (NTM)	48.10x	32.69x
Forward P/S (NTM)	8.72x	5.76x
Revenue & Growth
Revenue (TTM)	$4.49B	$2.78B
Revenue Growth (YoY)	4.9%	24.7%
Forward Rev Growth	6.3%	6.2%
Profitability
Gross Margin (TTM)	66.4%	28.8%
Operating Margin (TTM)	19.5%	21.0%
EBITDA Margin (TTM)	26.2%	22.0%
Net Margin (TTM)	18.4%	17.7%
FCF Margin (TTM)	20.7%	25.4%
Net Income (TTM)	$825M	$492M
FCF (TTM)	$931M	$707M
EPS (TTM)	$5.39	$17.21
ROE (TTM)	31.1%	110.1%
ROA (TTM)	12.7%	24.8%
ROIC (TTM)	17.8%	110.1%
Financial Health
Cash	$1.04B	$503M
Debt	$1.99B	$0
Net Cash/Debt	$-951M	$503M
Current Ratio (TTM)	1.80x	0.73x
Quick Ratio (TTM)	1.25x	0.66x
Debt/Equity (TTM)	0.70x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.43	1.11
52W Performance	184.5%	15.3%
YTD Performance	107.0%	7.2%
% from 52W High	-10.1%	-9.7%
% from 52W Low	216.1%	64.1%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	1.41x
FCF Yield (TTM)	2.2%	4.1%
Earnings Yield (TTM)	2.0%	2.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	25.6	50.1
EV/GP/RG	1.93	3.15
Ticker research	View ILMN research	View MEDP research

Valuation

P/E Ratio

MEDP

35.56x

ILMN

51.59x

P/S Ratio

MEDP

6.14x

ILMN

9.37x

EV/FCF

MEDP

23.46x

ILMN

46.23x

Growth & revenue

Revenue Growth TTM

MEDP

24.7%

ILMN

4.9%

Forward Revenue Growth

ILMN

6.3%

MEDP

6.2%

Profitability & performance

Gross Margin

ILMN

66.4%

MEDP

28.8%

ROE

MEDP

110.1%

ILMN

31.1%

FCF Yield %

MEDP

4.1%

ILMN

2.2%

52-Week Performance

ILMN

184.5%

MEDP

15.3%

Detailed metrics comparison

ILMN

Illumina Inc

MEDP

Medpace Holdings Inc

Market Cap

ILMN$42.09B

MEDP$17.08B

Enterprise Value

ILMN$43.04B

MEDP$16.58B

Price

ILMN$278.17

MEDP$612.05

P/E Ratio

ILMN51.59x

MEDP35.56x

P/S Ratio

ILMN9.37x

MEDP6.14x

EV/Sales

ILMN9.58x

MEDP5.96x

EV/EBITDA

ILMN36.11x

MEDP27.13x

P/B Ratio

ILMN14.53x

MEDP38.57x

P/FCF Ratio

ILMN45.21x

MEDP24.17x

EV/FCF

ILMN46.23x

MEDP23.46x

PEG Ratio

ILMN4.18x

MEDP2.97x

Forward P/E (NTM)

ILMN48.10x

MEDP32.69x

Forward P/S (NTM)

ILMN8.72x

MEDP5.76x

Revenue (TTM)

ILMN$4.49B

MEDP$2.78B

Revenue Growth (YoY)

ILMN4.9%

MEDP24.7%

Forward Rev Growth

ILMN6.3%

MEDP6.2%

Gross Margin (TTM)

ILMN66.4%

MEDP28.8%

Operating Margin (TTM)

ILMN19.5%

MEDP21.0%

EBITDA Margin (TTM)

ILMN26.2%

MEDP22.0%

Net Margin (TTM)

ILMN18.4%

MEDP17.7%

FCF Margin (TTM)

ILMN20.7%

MEDP25.4%

Net Income (TTM)

ILMN$825M

MEDP$492M

FCF (TTM)

ILMN$931M

MEDP$707M

EPS (TTM)

ILMN$5.39

MEDP$17.21

ROE (TTM)

ILMN31.1%

MEDP110.1%

ROA (TTM)

ILMN12.7%

MEDP24.8%

ROIC (TTM)

ILMN17.8%

MEDP110.1%

Cash

ILMN$1.04B

MEDP$503M

Debt

ILMN$1.99B

MEDP$0

Net Cash/Debt

ILMN$-951M

MEDP$503M

Current Ratio (TTM)

ILMN1.80x

MEDP0.73x

Quick Ratio (TTM)

ILMN1.25x

MEDP0.66x

Debt/Equity (TTM)

ILMN0.70x

MEDP0.00x

Debt/Assets (TTM)

ILMN0.0%

MEDP0.0%

Interest Coverage (TTM)

ILMNN/A

MEDPN/A

Net Debt/EBITDA (TTM)

ILMN0.00x

MEDP0.00x

Beta

ILMN1.43

MEDP1.11

52W Performance

ILMN184.5%

MEDP15.3%

YTD Performance

ILMN107.0%

MEDP7.2%

% from 52W High

ILMN-10.1%

MEDP-9.7%

% from 52W Low

ILMN216.1%

MEDP64.1%

Asset Turnover (TTM)

ILMN0.69x

MEDP1.41x

FCF Yield (TTM)

ILMN2.2%

MEDP4.1%

Earnings Yield (TTM)

ILMN2.0%

MEDP2.9%

Dividend Yield (TTM)

ILMNN/A

MEDPN/A

Rule of 40

ILMN25.6

MEDP50.1

EV/GP/RG

ILMN1.93

MEDP3.15

Ticker research

View ILMN research View MEDP research

Metric	ILMN Illumina Inc	MEDP Medpace Holdings Inc
Market & Valuation
Market Cap	$42.09B	$17.08B
Enterprise Value	$43.04B	$16.58B
Price	$278.17	$612.05
P/E Ratio	51.59x	35.56x
P/S Ratio	9.37x	6.14x
EV/Sales	9.58x	5.96x
EV/EBITDA	36.11x	27.13x
P/B Ratio	14.53x	38.57x
P/FCF Ratio	45.21x	24.17x
EV/FCF	46.23x	23.46x
PEG Ratio	4.18x	2.97x
Forward P/E (NTM)	48.10x	32.69x
Forward P/S (NTM)	8.72x	5.76x
Revenue & Growth
Revenue (TTM)	$4.49B	$2.78B
Revenue Growth (YoY)	4.9%	24.7%
Forward Rev Growth	6.3%	6.2%
Profitability
Gross Margin (TTM)	66.4%	28.8%
Operating Margin (TTM)	19.5%	21.0%
EBITDA Margin (TTM)	26.2%	22.0%
Net Margin (TTM)	18.4%	17.7%
FCF Margin (TTM)	20.7%	25.4%
Net Income (TTM)	$825M	$492M
FCF (TTM)	$931M	$707M
EPS (TTM)	$5.39	$17.21
ROE (TTM)	31.1%	110.1%
ROA (TTM)	12.7%	24.8%
ROIC (TTM)	17.8%	110.1%
Financial Health
Cash	$1.04B	$503M
Debt	$1.99B	$0
Net Cash/Debt	$-951M	$503M
Current Ratio (TTM)	1.80x	0.73x
Quick Ratio (TTM)	1.25x	0.66x
Debt/Equity (TTM)	0.70x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.43	1.11
52W Performance	184.5%	15.3%
YTD Performance	107.0%	7.2%
% from 52W High	-10.1%	-9.7%
% from 52W Low	216.1%	64.1%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	1.41x
FCF Yield (TTM)	2.2%	4.1%
Earnings Yield (TTM)	2.0%	2.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	25.6	50.1
EV/GP/RG	1.93	3.15
Ticker research	View ILMN research	View MEDP research